Literature DB >> 26338234

Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating Formulations.

Dajun D Sun1,2, Ping I Lee3.   

Abstract

Contrary to the early philosophy of supersaturating formulation design for oral solid dosage forms, current evidence shows that an exceedingly high rate of supersaturation generation could result in a suboptimal in vitro dissolution profile and subsequently could reduce the in vivo oral bioavailability of amorphous solid dispersions. In this commentary, we outline recent research efforts on the specific effects of the rate and extent of supersaturation generation on the overall kinetic solubility profiles of supersaturating formulations. Additional insights into an appropriate definition of sink versus nonsink dissolution conditions and the solubility advantage of amorphous pharmaceuticals are also highlighted. The interplay between dissolution and precipitation kinetics should be carefully considered in designing a suitable supersaturating formulation to best improve the dissolution behavior and oral bioavailability of poorly water-soluble drugs.

Entities:  

Keywords:  amorphous formulation; kinetic solubility; nonsink dissolution testing; poorly water-soluble drug; supersaturation rate

Mesh:

Substances:

Year:  2015        PMID: 26338234      PMCID: PMC4627464          DOI: 10.1208/s12248-015-9825-6

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  26 in total

1.  Dissolution rates of high energy sulfathiazole--povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies.

Authors:  A P Simonelli; S C Mehta; W I Higuchi
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

Review 2.  Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.

Authors:  Dallas B Warren; Hassan Benameur; Christopher J H Porter; Colin W Pouton
Journal:  J Drug Target       Date:  2010-10-26       Impact factor: 5.121

Review 3.  Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?

Authors:  Joachim Brouwers; Marcus E Brewster; Patrick Augustijns
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

Review 4.  Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues.

Authors:  Jan Bevernage; Joachim Brouwers; Marcus E Brewster; Patrick Augustijns
Journal:  Int J Pharm       Date:  2012-11-27       Impact factor: 5.875

5.  Maintenance of supersaturation II: indomethacin crystal growth kinetics versus degree of supersaturation.

Authors:  Dhaval D Patel; Bradley D Anderson
Journal:  J Pharm Sci       Date:  2013-03-11       Impact factor: 3.534

6.  Dissolution and precipitation behavior of amorphous solid dispersions.

Authors:  David E Alonzo; Yi Gao; Deliang Zhou; Huaping Mo; Geoff G Z Zhang; Lynne S Taylor
Journal:  J Pharm Sci       Date:  2011-05-23       Impact factor: 3.534

7.  Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. IV. Chloramphenicol--urea system.

Authors:  A H Goldberg; M Gibaldi; J L Kanig; M Mayersohn
Journal:  J Pharm Sci       Date:  1966-06       Impact factor: 3.534

8.  Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.

Authors:  Dajun D Sun; Tzu-chi Rob Ju; Ping I Lee
Journal:  Eur J Pharm Biopharm       Date:  2012-01-02       Impact factor: 5.571

9.  Physicochemical characterization and drug release studies of nilvadipine solid dispersions using water-insoluble polymer as a carrier.

Authors:  Noriyuki Hirasawa; Sayoko Ishise; Hitomi Miyata; Kazumi Danjo
Journal:  Drug Dev Ind Pharm       Date:  2003-03       Impact factor: 3.225

Review 10.  Crosslinked hydrogels-a promising class of insoluble solid molecular dispersion carriers for enhancing the delivery of poorly soluble drugs.

Authors:  Dajun D Sun; Ping I Lee
Journal:  Acta Pharm Sin B       Date:  2014-01-22       Impact factor: 11.413

View more
  4 in total

1.  Clinical pharmacokinetics of an amorphous solid dispersion tablet of elacridar.

Authors:  Emilia Sawicki; Remy B Verheijen; Alwin D R Huitema; Olaf van Tellingen; Jan H M Schellens; Bastiaan Nuijen; Jos H Beijnen; Neeltje Steeghs
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

Review 2.  Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery.

Authors:  Anna Karagianni; Kyriakos Kachrimanis; Ioannis Nikolakakis
Journal:  Pharmaceutics       Date:  2018-07-19       Impact factor: 6.321

3.  Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers.

Authors:  Afroditi Kapourani; Theodora Tzakri; Vasiliki Valkanioti; Konstantinos N Kontogiannopoulos; Panagiotis Barmpalexis
Journal:  Int J Pharm X       Date:  2021-06-05

4.  Dose-Dependent Solubility-Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions.

Authors:  Kazuya Sugita; Noriyuki Takata; Etsuo Yonemochi
Journal:  Pharmaceutics       Date:  2021-03-02       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.